Role of putative cytotoxins in Chlamydia infection
- Institution
- UNIVERSITY OF KENTUCKY, KY
- Principal investigator
- Kenneth A Fields
- Funding
- $186K
- Duration
- 2024–2026
Moonbase score
Still being scored
Abstract
ABSTRACT Chlamydia species are important pathogens that represent a paradigm for understanding successful obligate intracellular parasitism. C. trachomatis is a prevalent human pathogens, whereas C. muridarum is a murine-specific pathogen often used to study chlamydial disease in a small animal model. Species-specific variability in coding capacity within the so-called plasticity zone of the chlamydial chromosome is thought to be one source dictating differences in infection biology. The presence/absence of genes encoding glycosyltransferases designated as putative cytotoxins represents an intriguing example of this diversity. C. muridarum express multiple homologous proteins that also show similarity to a family of larger cytotoxins. The plasticity zone of common urogenital C. trachomatis serovars express a truncated protein while ocular serovars of members of the lymphogranuloma venereum (LGV) biovar lack the toxin genes completely. These cytotoxins have been proposed to mediate immediate toxicity in highly infected epithelial cells by interfering with actin polymerization. Lack of tractable genetics in C, muridarum and urogenital C. trachomatis, in particular has previously confounded definitive studies, leading to a paucity in details regarding molecular mechanisms of infection. We have overcome this barrier by deletion of putative cytotoxin genes in C. muridarum. Our data indicated that these proteins were dispensable for immediate toxicity. Combined with analysis of C. trachomatis CT166, our data implicate an alternative function for these proteins. We propose to apply genetic and biochemical approaches to delineate molecular function(s) of these putative glycosyltransferases and address their contribution(s) to species-specific infection biology.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF KENTUCKY
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of KentuckyNot yet scored
Saturating transposon mutagenesis for Chlamydia
Kenneth A Fields · $190K · 2024–2026
- NIH · University of KentuckyNot yet scored
Chlamydia type III effectors affecting the host actin-based cytoskeleton
Kenneth A Fields · $544K · 2023–2028
- NIH · University of Kentucky66
HPV16 E6 Antibody Detection as an Early Marker for Oropharyngeal Cancer Among Men Living with HIV
Krystle A. Kuhs · $219K · 2021–2026